`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`____________
`
`KOIOS PHARMACEUTICALS LLC
`
`Petitioner
`
`v.
`
`MEDAC GESELLSCHAFT FUER KLINISCHE SPEZIALPRÄPARATE MBH
`
`Patent Owner
`____________
`
`IPR2016-01370
`Patent No. 8,664,231
`Title: Concentrated Methotrexate Solutions
`
`
`Second Declaration of Scott E. Kamholz
`
`
`Koios Exhibit 1037
`
`
`
`
`
`
`
`
`
`
`
`
`I, Scott E. Kamholz, declare:
`
`1.
`I am an attorney at Foley Hoag LLP, and counsel of record for Koios
`
`Pharmaceuticals LLC in the above-captioned matter. I am registered to practice
`before the United States Patent and Trademark Office.
`
`2.
`Paragraph 15 of Exhibit 1034 (“Declaration of Dr. Michael H.
`Schiff ”) has been partially redacted in an abundance of caution and to afford
`Medac the opportunity to move to seal that information if it contends the
`information is confidential. Koios does not believe, however, that any of the
`information contained in Paragraph 15 should be deemed confidential under 37
`C.F.R. § 42.2.
`
` I
`
` declare, under penalty of perjury under the laws of the United States, that
`the foregoing is true and accurate.
`
`Dated: July 20, 2016
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`/SCOTT E. KAMHOLZ/
`Scott E. Kamholz
`
`
`1